Cash from Operations (TTM) Chart

View Cash from Operations (TTM) for PAVM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (TTM) Chart
Start Trial

Historical Cash from Operations (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 -7.73M
March 31, 2026 -6.245M
December 31, 2025 -5.206M
September 30, 2025 -3.561M
June 30, 2025 -11.55M
March 31, 2025 -22.03M
December 31, 2024 -33.55M
September 30, 2024 -45.52M
June 30, 2024 -47.73M
March 31, 2024 -48.86M
December 31, 2023 -52.04M
September 30, 2023 -56.98M
June 30, 2023 -65.24M
March 31, 2023 -75.01M
December 31, 2022 -70.98M
September 30, 2022 -70.94M
June 30, 2022 -59.62M
March 31, 2022 -43.69M
December 31, 2021 -40.59M
September 30, 2021 -30.54M
June 30, 2021 -28.36M
March 31, 2021 -27.29M
Date Value
December 31, 2020 -21.91M
September 30, 2020 -19.28M
June 30, 2020 -16.32M
March 31, 2020 -13.28M
December 31, 2019 -13.36M
September 30, 2019 -12.29M
June 30, 2019 -11.27M
March 31, 2019 -10.46M
December 31, 2018 -8.788M
September 30, 2018 -7.356M
June 30, 2018 -7.862M
March 31, 2018 -6.983M
December 31, 2017 -6.608M
September 30, 2017 -6.224M
June 30, 2017 -5.078M
March 31, 2017 -5.761M
December 31, 2016 -4.455M
September 30, 2016 -3.900M
June 30, 2016 -2.991M
March 31, 2016 -1.711M
December 31, 2015 -1.250M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Abbott Laboratories 9.905B
AngioDynamics, Inc. 3.089M
Alphatec Holdings, Inc. 56.52M
AtriCure, Inc. 64.94M
Baxter International, Inc. 1.319B